Search Results (2,028)

A heteroatom-rich pyridine-based adsorbent (Pyridine PC) was synthesized through a multicomponent strategy and structurally confirmed by ¹H/¹³C NMR spectroscopy and mass spectrometry. To further enhance adsorption activity and surface reactivity, waste-derived CuO nanoparticles were immobilized onto the porous heterocyclic framework, generating a sustainable CuO@Pyridine PC hybrid nanocomposite. Batch adsorption experiments demonstrate highly efficient removal of malachite green (MG) dye and Cd(II) ions from aqueous solutions. Kinetic analysis reveals that adsorption follows the pseudo-second-order model, while equilibrium data are best described by the Freundlich isotherm, indicating adsorption on heterogeneous surfaces. Thermodynamic parameters confirm that the adsorption processes are spontaneous and exothermic. Surface and structural characterization using SEM/EDX, elemental mapping analysis and FT-IR before and after adsorption verifies strong pollutant binding and highlights the role of nitrogen- and oxygen-containing functional groups as dominant interaction sites. BET measurements show that CuO incorporation increases surface area and pore volume, while zeta potential analysis indicates excellent colloidal stability of the composite in aqueous media. Consequently, the CuO-modified sorbent exhibits enhanced adsorption capacities, increasing from 169.8 to 176.13 mg g⁻¹ for MG and from 276.5 to 368 mg g⁻¹ for Cd(II). The adsorbent demonstrated effective pollutant removal from real wastewater. The adsorption mechanism involves synergistic interactions between functional groups in the Pyridine PC matrix and CuO nanoparticles, providing enhanced active binding sites. Full article

With the rapid intensification of industrial and agricultural activities, water contamination by heavy metal ions has emerged as a critical global challenge, gravely imperiling ecosystem stability and public health. Among the various remediation technologies, adsorption has been widely adopted due to its high efficiency, low-cost water treatment, and simplicity of operation. However, conventional inorganic or synthetic adsorbents often exhibit poor degradability and pose a risk of secondary contamination, substantially limiting their sustainable application. Consequently, the development of environmentally benign and renewable adsorbent materials has become a central research focus in this field. Recently, cellulose-based composite hydrogels, derived from renewable resources and characterized by excellent eco-friendliness and highly tunable three-dimensional porous structures, have attracted considerable attention as promising green adsorption materials. These hydrogels demonstrate outstanding performance in the efficient sequestration of heavy metal contaminants from aqueous environments. This review systematically summarizes recent advances in cellulose-based composite hydrogels for heavy metal removal, to elucidate the structure–performance relationships linking material fabrication strategies, structural modulation, and adsorption efficiency. First, we outline the principal construction approaches, including physical crosslinking, chemical modification, and supramolecular self-assembly, and comprehensively analyze how different synthesis routes regulate pore architecture, mechanical properties, and the distribution of surface functional groups. Second, the underlying adsorption mechanisms, primarily coordination complexation, electrostatic interactions, and ion exchange, are discussed in detail. Finally, recent studies on the adsorption of cationic heavy metals (e.g., Pb(II), Cu(II), and Cd(II)) and anionic oxyanions (e.g., As(III) and Cr(VI)) are critically reviewed, with particular emphasis on the relationships between selective adsorption performance, material design principles, and specific recognition mechanisms. Overall, this review provides a theoretical foundation and practical guidance for the design and development of next-generation water treatment materials with high adsorption capacity, excellent selectivity, non-toxicity, and strong environmental compatibility, followed by future research recommendations. Full article

Difficult-to-treat systemic lupus erythematosus (D2T-SLE) remains a major unmet challenge in contemporary lupus care, yet it continues to be defined predominantly by clinical non-response rather than underlying biology. Current biomarkers largely quantify inflammatory burden, immune complex activity, or organ damage and do not reliably capture persistent activation of pathogenic pathways under therapy. Emerging multi-omics, single-cell, and longitudinal studies suggest that, in a subset of patients, apparent treatment failure may reflect incomplete attenuation of dominant immune circuits rather than uniformly elevated inflammation. We propose molecular refractoriness in systemic lupus erythematosus (SLE) as sustained, pathway-level immune activity despite apparently adequate, mechanism-directed therapy. We outline the major immune programs implicated in this process—including interferon-enriched, B-cell/plasmablast-associated, neutrophil extracellular trap (NET)-related, cytotoxic T-cell, and cytokine-associated states—and discuss their relevance for biomarker development and precision trial design. Importantly, we emphasize that interferon gene signatures (IGS) should be interpreted as context-dependent and non-specific markers of interferon responsiveness, reflecting combined activity of type I, II, and III interferons, and functioning primarily as predictive rather than mechanistic biomarkers. We further highlight critical limitations of a purely endotype-based model, including the need to distinguish true molecular refractoriness from damage-dominant and pseudo-refractory states, as well as the emerging role of immune-reset strategies such as cluster of differentiation 19 (CD19)-directed chimeric antigen receptor T-cell (CAR-T) therapy, which may overcome refractoriness independently of specific pathway dominance. These observations suggest that difficult-to-treat SLE encompasses biologically heterogeneous states that may not be fully captured by pathway-resolved stratification alone. Reframing D2T-SLE as a biologically heterogeneous state of incomplete immune attenuation may help bridge the gap between clinical treatment failure and mechanism-informed precision medicine in systemic lupus erythematosus. Full article

Introduction: Soft tissue sarcomas (STS) exhibit profound molecular heterogeneity. While recurrent gene fusions hold significant diagnostic and therapeutic value—guiding treatment selection and identifying novel molecular targets—our understanding of their broader clinical implications remains limited. Materials and Methods: We performed next-generation sequencing (NGS; FusionPlex Sarcoma v2, Archer™) and bioinformatic analysis (STAR v.2.7, Arriba) on formalin-fixed paraffin-embedded (FFPE) core needle biopsy specimens. The cohort consisted of patients enrolled in a phase II clinical trial (NCT03651375) who received preoperative chemoradiotherapy according to the UNRESARC protocol. Results: The analysed cohort comprised nine adult patients (median age 66 years; range 44–73) diagnosed with undifferentiated pleomorphic sarcoma (UPS; n = 3), malignant peripheral nerve sheath tumour (MPNST; n = 3), myxofibrosarcoma (MFS; n = 2), and leiomyosarcoma (LMS; n = 1), predominantly high-grade (G3; 5/9) and extremity-localised (6/9). Gene fusions were detected in one-third of patients (3/9), exclusively in G3 tumours. Specifically, we identified an SGSH-PRKCA fusion in MFS (thigh), a LINC01133-OGA fusion in MPNST (thorax), and a concurrent JAZF1-MYH7B (chr7:27995037 intronic-chr20:33563203 exon/splice-site, out-of-frame but preserving myosin domains) with a PRKCA-associated intergenic rearrangement (chr1, retaining C1/kinase domains) in UPS (upper back). Notably, the SGSH-PRKCA and JAZF1-MYH7B pairs have not been previously described in the literature for these STS subtypes. Fusion-positive (F1) cases showed stable radiological disease (RECIST 1.1 SD) and EORTC C/D pathological responses with 5–20% residual viable tumour, whereas fusion-negative (F0) cases showed a wider range of radiological and pathological outcomes, including partial response, progression, and stable disease. Conclusions: Our analysis suggests that broad genomic profiling may provide complementary molecular information in diagnostically challenging cases managed at specialised sarcoma centres, particularly when morphology and immunohistochemistry are insufficient. In the present series, however, the detected rearrangements did not alter systemic treatment, and the data do not support claims of prognostic, predictive, or therapeutic actionability. Full article

Background: The emergence of SARS-CoV-2 variants necessitates the development of effective adjuvants to enhance subunit vaccine immunogenicity. Safe adjuvants are essential to enhance the immunogenicity of SARS-CoV-2 receptor-binding domain (RBD) subunit vaccines. Traditional Chinese medicine polysaccharides are attractive candidates due to their immunomodulatory properties. Methods: Female BALB/c mice (6–8 weeks) were immunized on days 0, 7, and 21 with an RBD protein (20 μg) alone or formulated with Poria cocos polysaccharide fraction PCP-I or PCP-II (200 μg), Isatis indigotica polysaccharide, or aluminum adjuvant; PBS served as a control. RBD-specific total IgG and subclasses were quantified by ELISA on day 7 after the third immunization. Neutralizing antibody titers were measured by a pseudovirus assay on days 14, 28, and 56 after the first immunization. Splenic CD19⁺ B cells were analyzed by flow cytometry, and antigen-stimulated IFN-γ and IL-4 spot-forming cells were quantified by ELISpot. Results: PCP-II significantly increased RBD-specific total IgG and IgG1 compared with RBD alone and other formulations, whereas IgG2a and IgG2b remained unchanged. Both PCP-I and PCP-II increased neutralizing titers versus RBD alone, and PCP-II showed an earlier and sustained increase in neutralizing responses through day 56. PCP-II showed a non-significant increase in splenic CD19⁺ B cell frequency. PCP-I and PCP-II markedly increased IFN-γ-secreting splenocytes without increasing IL-4, indicating enhanced antigen-specific cellular responses. Conclusion: In this comparative evaluation of traditional Chinese medicine polysaccharide candidates in a SARS-CoV-2 RBD subunit vaccine model, PCP-II showed the most prominent adjuvant activity. PCP-II enhanced antigen-specific humoral immunogenicity, improved neutralizing antibody responses, and was associated with increased IFN-γ-related cellular responses, supporting its potential as a candidate polysaccharide adjuvant for protein subunit vaccines. Full article

Antioxidant supplementation during in vitro maturation (IVM) has been proposed as a strategy to influence transcriptional responses in oocytes and cumulus–oocyte complexes. In this study, we investigated whether vitamin C, rosmarinic acid, or quercetin influence the expression of key fertilisation-associated genes (CD9, ITGA6, MFGE8, ZP2, and ZP3) in porcine cumulus–oocyte complexes (COCs). COCs were classified into three intrinsic quality groups (I–III) and matured in the presence or absence of antioxidants. Gene expression was quantified by RT-qPCR and analysed using a two-way ANOVA model to assess the effects of COC quality and treatment. ZP2 and ZP3 transcript levels were consistently lower in class II and III COCs than in class I controls (p < 0.001). Antioxidant supplementation was associated with treatment- and quality-dependent differences in gene expression. Quercetin was associated with the most pronounced upregulation, with Q I increasing ZP2 expression to 2.95-fold and ZP3 to 2.43-fold relative to class I controls (p < 0.001). Vitamin C was also associated with increased transcript abundance across several treatment groups, including class II and class III COCs, whereas rosmarinic acid exhibited more moderate and gene-specific effects. In contrast, MFGE8 expression, which was elevated in lower-quality COCs, was reduced in antioxidant-treated class II and III complexes. These findings provide transcript-level evidence that antioxidant exposure during IVM is associated with treatment- and quality-dependent changes in fertilisation-related gene expression in porcine COCs. Full article

Cadmium (Cd), a common environmental and occupational toxicant, is an important risk factor for neurodegenerative diseases. Metformin has been found to have neuroprotective effect, in addition to antidiabetic function. Our recent studies have identified that metformin ameliorates Cd neurotoxicity via blocking ROS-dependent PP5/AMPK-JNK signaling pathway. Here we further show that metformin protected PC12 cells and primary neurons from Cd-poisoning by mitigating Cd-induced increases in ATG5/LC3-II/p62 levels and autophagosomes. Knockdown of ATG5 dramatically potentiated the inhibitory effects of metformin on Cd-induced LC3-II, cleavage of caspase-3, accumulation of autophagosomes and apoptosis in PC12 cells. Addition of chloroquine (CQ) strengthened the basic and Cd-elevated ATG5/LC3-II/p62 levels, autophagosome accumulation and cell apoptosis, whereas metformin powerfully blocked the events, implying a metformin-promoted autophagic flux-dependent mechanism involved. Further research revealed that metformin prevented Cd-induced autophagic flux impairment and cell apoptosis, which was attributed to restraining Cd inactivation of AMPK. This is supported by the findings that activation of AMPK with AICAR or ectopic expression of constitutively active AMPKα (AMPKα-ca) reinforced the inhibitory effects of metformin on Cd-evoked ATG5/LC3-II/p62/autophagosomes and apoptosis in PC12 cells and/or primary neurons. Taken together, the results indicate that metformin protects neuronal cells from Cd-induced autophagic flux impairment-dependent apoptosis by activating AMPK. Our studies highlight that metformin has a great potential for prevention of Cd toxicity related to neurodegenerative diseases. Full article

The semiconductor industry has long relied on Statistical Process Control (SPC) for yield and reliability management. In early technology nodes, classic univariate tools such as Shewhart charts, cumulative sums (CUSUM), exponentially weighted moving averages (EWMA), and the Cp/Cpk exponent could effectively monitor a finite set of key variables. However, sub-5nm and emerging 3 nm technologies have fundamentally changed the statistical environment. Advanced patterning, high-aspect-ratio etching, atomic layer deposition (ALD), chemical-mechanical polishing (CMP), and novel materials have drastically narrowed the process window. At these scales, nanometer-level deviations in critical dimensions (CD), overlay, or surface roughness can significantly impact yield. Simultaneously, modern wafer fabs generate massive amounts of high-frequency sensor data and high-dimensional metrology data. Traditional SPC assumptions—such as independence, normality, low dimensionality, and stationarity—often do not hold. Semiconductor data exhibits: (i) extremely high-dimensionality and strong intervariate correlations; (ii) a hierarchical structure encompassing fab → tooling → chamber → recipe → batch → wafer → field; and (iii) metrological delays and sampling limitations leading to incomplete and asynchronous observations. To address these challenges, this paper reviews advanced statistical methods applicable to wafer fabrication. These methods include multivariate statistical process control (MSPC) approaches such as Hotelling T² statistics, PCA/PLS combining T² and Q statistics, contribution diagnostics, time-series drift and change point detection, and Bayesian hierarchical modeling for uncertainty-aware monitoring in data-limited scenarios. Furthermore, we discuss how to integrate these methods with fault detection and classification (FDC), line-to-line monitoring (R2R), advanced process control (APC), and manufacturing execution systems (MES). This paper focuses on scalable, interpretable, and maintainable implementations that transform statistical analysis from a passive monitoring tool into an active component of data-driven fab control. Full article

Telmisartan, an angiotensin II type 1 receptor blocker with established anti-inflammatory and antihypertensive properties, has been reported to inhibit tumor cell proliferation, yet its impact on the tumor immune microenvironment remains poorly understood. In this study, we evaluated the immunomodulatory effects of telmisartan using a syngeneic MC38 colorectal cancer model in C57BL/6 mice. Daily intragastric administration of telmisartan significantly suppressed tumor growth and reduced endpoint tumor weight compared with controls. To elucidate the underlying mechanisms, we performed single-cell RNA sequencing on tumor-infiltrating CD45⁺ immune cells and revealed a macrophage-dominated immune landscape comprising multiple transcriptionally distinct subclusters. Telmisartan broadly downregulated pro-tumoral and M2-associated macrophage programs, including decreased expression of genes such as Mrc1 and Spp1, while also suppressing cell proliferation-related pathways. In contrast to its overall suppressive impact on macrophages, telmisartan increased the proportion of cytotoxic CD8⁺ T cells, reduced regulatory T cell counts, and enhanced major histocompatibility complex class I antigen presentation, consistent with an immune-activating effect. These results indicate that telmisartan reshapes the colorectal tumor immune microenvironment by simultaneously attenuating tumor-promoting macrophage activity and augmenting cytotoxic T cell responses. Overall, this study provides a single-cell framework to understand how angiotensin receptor blockade reshapes tumor-infiltrating immune programs, highlighting the translational potential of repurposing telmisartan for novel cancer immunotherapy strategies. Full article

Betaine-homocysteine methyltransferase (BHMT) is an enzyme involved in one-carbon metabolism and plays a crucial role in maintaining liver health. In this study, we investigated the impact of liver-specific deletion of BHMT on liver dysfunction using a mouse model. We generated BHMT floxed mice and bred them with albumin Cre to generate liver-specific BHMT knockout (BHMT LKO) mice. Liver tissues harvested from six-month-old chow-fed BHMT floxed and LKO mice were characterized through histological, biochemical, and molecular analyses. BHMT LKO mice displayed a complete loss of hepatic expression of BHMT mRNA, protein and enzyme activity. Histopathological analysis revealed the development of hepatic steatosis in BHMT LKO mice compared to the floxed mice. These morphological changes were supported by biochemical analysis showing elevated levels of hepatic triglycerides in conjunction with a profound decrease in the methylation potential (i.e., reduced S-adenosylmethionine (SAM): S-adenosylhomocysteine (SAH) ratio), which was mainly driven by a six- to sevenfold increase in SAH levels. BHMT LKO mice also exhibited increased lipid peroxidation and lysosomal dysfunction compared to floxed mice. Early signs of inflammation were seen in the livers of BHMT LKO mice of both sexes, as evident from significant increase in CD68-positive cells and interleukin 1β levels. Additionally, there was a moderate increase in fibrosis, as evidenced by the upregulated expression of α-smooth muscle actin and collagen II levels and the histological assessment of picrosirius red-stained liver sections of BHMT LKO mice of both sexes compared to their respective counterparts. These findings demonstrate that hepatic BHMT deficiency promotes lipid accumulation, lysosomal/proteasomal dysfunction, and early inflammatory and fibrotic changes in the liver by reducing the methylation potential. Collectively, our results underscore BHMT as a critical regulator of liver homeostasis and a potential therapeutic target in liver-related disorders. Full article

Chitosan is a well-known heavy metal biosorbent and was incorporated into birch sanding dust mycelium bio-composites (MBs). The chitosan-hybridized MBs with different chitosan contents were characterized by microscopy, porous structure analyses (specific surface area and total pore volume), pH_pzc, functional group content, and FTIR. Microscopy did not reveal any antifungal effect of chitosan on Trametes versicolor. The porous structure of the MBs decreased after hybridization with chitosan. The FTIR spectra and functional group analyses confirmed the presence of chitosan amino groups in the MBs. The chitosan-hybridized MBs were subjected to the adsorption of heavy metals, namely Cu(II) and Cd(II), and the removal percentage and adsorption isotherms were evaluated. Adsorption isotherms were analyzed using the Freundlich and Langmuir models. The results showed a significant increase in the maximum monolayer adsorption capacity for Cu(II), calculated using the Langmuir equation, from <2 mg/g for raw BSD and basic MB without chitosan to 19 mg/g for the MB with 15% chitosan. In the case of Cd(II), no significant increase in adsorption capacity was observed. These findings indicate that hybridization of MBs with chitosan is a promising approach to improve the Cu(II) adsorption capacity of MBs. Full article

Background: Treatment response to neoadjuvant therapy in rectal cancer exhibits a considerable degree of interpatient heterogeneity. Select components of the tumour immune microenvironment have been identified as predictive biomarkers of therapeutic response, for which more evidence is required for future clinical prediction models. Aim: The research aimed to identify key tumour immune microenvironment biomarkers predictive of the response to neoadjuvant therapy through the systematic appraisal of existing literature. Methods: A structured search was performed across PubMed, Ovid Embase, and Cochrane databases to retrieve primary studies investigating the association between the tumour immune microenvironment and pathological complete response (pCR) or tumour regression grade (TRG) in patients with rectal cancer. Studies were screened against predefined inclusion and exclusion criteria. Results: Fifteen studies satisfied the inclusion criteria, with cohorts ranging between 24 and 298 participants with predominantly stage II–III disease. Considerable heterogeneity was observed in both types and methods of quantification of biomarkers. Biomarkers assessed in pretreatment biopsies included tumour-infiltrating lymphocytes (TILs), investigated by subtype (cluster of differentiation (CD)8+, CD4+, forkhead box protein 3+ (FOXP3)) or as a composite measure, as well as programmed death-ligand 1 (PD-L1), PD-1+, natural killer (NK) cells, CD163+, and CD68+. Findings showed that high densities of TILs—particularly the CD8+ subtype—consistently correlated with improved tumour regression. FOXP3+ and CD163+ were inconsistently associated with reduced treatment response. NK cells and CD68+ cells were less frequently investigated and yielded non-significant findings. Conclusions: CD8+ TILs have the potential to serve as predictive biomarkers of therapeutic response to neoadjuvant treatment in patients with rectal cancer. Inconsistent findings with FOXP3+ Tregs and CD163+ macrophages reinforce the need for their further investigation. Full article

Chronic wounds are ulcers unable to heal due to vascular insufficiency, diabetes, or obesity. Adipose-derived stromal cells (ASCs) are promising candidates for regenerative therapies owing to their pro-healing and angiogenic properties. Compared with autologous approaches, allogeneic ASC therapies offer the opportunity for off-the-shelf use, enabling immediate availability, standardized qualification, and consistent potency. Gelatin sponges have been shown to reprogram ASCs toward a highly angiogenic phenotype. However, because this activation also modulates some immune-related genes, including MHC, its impact on immunogenicity is unknown and could be critical for allogeneic applications. This study evaluated whether ASCs embedded in a gelatin sponge could be used in an allogeneic setting for ischemic wound repair. To mimic clinical allogeneic conditions, a controlled MHC mismatch was introduced in a rat ischemic wound model: donor ASCs carrying RT1^n or RT1^l haplotypes were implanted into outbred RT1^a recipients. Embedding ASCs within the gelatin sponge upregulated MHC class I but not class II expression, without inducing systemic or local alloreactivity. Serum acute-phase proteins remained unchanged, and no CD3⁺ T-cell infiltration was detected. Histology confirmed efficacy on ischemic wounds, with increased granulation tissue thickness, red blood cell infiltration, and enhanced vessel density versus controls. Allogeneic ASCs activated by a gelatin scaffold promote wound revascularization without eliciting immune rejection, supporting their development as standardized, off-the-shelf therapies for chronic ischemic wounds. Full article

G-quadruplexes (G4s) are noncanonical nucleic acid structures involved in gene regulation and genome stability. Among them, the telomeric repeat-containing RNA (TERRA) forms biologically relevant RNA G4s (rG4s) that participate in telomere maintenance and genome stability. Although many ligands targeting DNA G4s have been reported, the recognition and modulation of RNA G4 topologies remain less explored. In this work, we investigated the interaction between TERRA and the spermine-functionalized Zn(II) porphyrin, ZnTCPPSpm4, using UV–vis absorption, fluorescence, resonance light scattering (RLS), and circular dichroism (CD) spectroscopy. In K⁺, where TERRA adopts a parallel G4 conformation, ZnTCPPSpm4 binds through a stepwise mechanism involving external end-stacking, forming discrete supramolecular complexes without altering the native topology. In contrast, under Na⁺ conditions, ZnTCPPSpm4 induces a gradual conformational rearrangement of TERRA from the antiparallel to a parallel-like G4 topology. A CD melting study showed that ZnTCPPSpm4 stabilizes the parallel RNA G4, while slightly destabilizing the antiparallel topology. Overall, our results demonstrate that ZnTCPPSpm4 is not a simple G4 binder, but a topology-selective ligand capable of remodeling TERRA G4 structures, highlighting the potential of metalloporphyrins as RNA G4-targeting scaffolds. Full article

Six 1,4-disubstituted pyrazoles linked to a benzenesulfonamide and a benzodioxane unit have been synthesized through a copper(I)-catalyzed formal [3+2] cycloaddition (32CA) reaction of alkynes with 3-arylsydnones. The Cu-catalyzed sydnone–alkyne cycloaddition (CuSAC) procedure has been optimized to promote the formation of the pyrazole ring and to deliver in three steps the six target compounds 5a–f, fully characterized by ¹H/¹³C-NMR and mass spectrometry (EIMS). Ten solvent conditions were evaluated. The reaction proceeded most efficiently in the presence of copper(II) sulfate pentahydrate in aqueous t-butanol in the presence sodium acetate, to reach a yield of 96%. The mechanism of the Cu(I)-catalyzed reaction has been studied within the Molecular Electron Density Theory (MEDT). This rection is a domino process that consists in a Cu(I)-catalyzed formal [3+2] cycloaddition followed of an extrusion of CO₂ yielding the final pyrazole. The capacity of heterocyclic compounds 5a–f to interact with human cyclophilin A (Cyp A), which is a host cofactor for hepatitis C virus (HCV) and human immunodeficiency virus 1 (HIV-1), and with the HIV-1 protein gp120-CD4 was evaluated using molecular docking. Compounds 5a,b,d,f showed a satisfactory protein binding capacity. The physicochemical and metabolic properties of the compounds were also evaluated in silico. These predictions provide important information to guide future design in this series of potential antiviral agents. Full article